Self-assembled polysaccharide nanostructures for controlled-release applications

Nanotechnology Reviews

Volumn 3, Issue 4, 2014, Pages 319-346

  Myrick, James M ^b   Vendra, Venkat Kalyan ^a,b   Krishnan, Sitaraman ^b  

^a University of Louisville ^*  (United States)

^b Wallace H Coulter School of Engineering   (United States)

Author keywords

Controlled release; Polysaccharides; Selfassembly; Stimulus responsive nanoparticles

Indexed keywords

CYCLODEXTRINS; POLYELECTROLYTES; POLYSACCHARIDES; SELF ASSEMBLY;

ACTIVE PHARMACEUTICAL INGREDIENTS; CHEMICAL FUNCTIONALIZATION; CONTROLLED RELEASE; INTERMOLECULAR INTERACTIONS; MODIFIED POLYSACCHARIDES; NANOSTRUCTURE FORMATION; PERMEABILITY CHARACTERISTICS; POLYELECTROLYTE COMPLEXES;

NANOPARTICLES;

EID: 84924422348     PISSN: 21919089     EISSN: 21919097     Source Type: Journal    
DOI: 10.1515/ntrev-2012-0050     Document Type: Review

References (132)

1. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2001, 48, 139-157.
2. Mizrahy S, Peer D. Polysaccharides as building blocks for nanotherapeutics. Chem. Soc. Rev. 2012, 41, 2623-2640.
3. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 2008, 5, 505-515.
4. Mehvar R. Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation. J. Pharm. Pharmaceut. Sci. 2000, 1, 125-136.
5. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46, 6387-6392.
6. Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Delivery Rev. 2011, 63, 131-135.
7. Cuomo F, Lopez F, Ceglie A, Maiuro L, Miguel MG, Lindman B. pH-responsive liposome-templated polyelectrolyte nanocapsules. Soft Matter 2012, 8, 4415-4420.
8. Choochottiros C, Yoksan R, Chirachanchai S. Amphiphilic chitosan nanospheres: factors to control nanosphere formation and its consequent pH-responsive performance. Polymer 2009, 50, 1877-1886.
9. She W, Li N, Luo K, Guo C, Wang G, Geng Y, Gu Z. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials 2013, 34, 2252-2264.
10. Dufort S, Sancey L, Coll J. Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution. Adv. Drug Delivery Rev. 2012, 64, 179-189.
11. Hirota, K, Terada, H. Endocytosis of particle formulations by macrophages and its application to clinical treatment. In Molecular Regulation of Endocytosis, Ceresa, B, Ed., InTech: Croatia, 2012, pp. 413-428.
12. Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv. Drug Deliv. Rev. 2008, 60, 915-928.
13. Chua BY, Al Kobaisi M, Zeng W, Mainwaring D, Jackson DC. Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines. Mol. Pharm. 2012, 9, 81-90.
14. Ding X, Yao P. Soy protein/soy polysaccharide complex nanogels: folic acid loading, protection, and controlled delivery. Langmuir 2013, 29, 8636-8644.
15. Tree-udom T, Wanichwecharungruang SP, Seemork J, Arayachukeat S. Fragrant chitosan nanospheres: controlled release systems with physical and chemical barriers. Carbohydr. Polym. 2011, 86, 1602-1609.
16. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Delivery Rev. 2008, 60, 1650-1662.
17. Liu Y, Yang J, Zhao Z, Li J, Zhang R, Yao F. Formation and characterization of natural polysaccharide hollow nanocapsules via template layer-by-layer self-assembly. J. Colloid Interface Sci. 2012, 379, 130-140.
18. Cheng R, Meng F, Deng C, Klok H, Zhong Z. Dual and multistimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 2013, 34, 3647-3657.
19. Chuang C, Don T, Chiu W. Preparation of environmentalresponsive chitosan-based nanoparticles by self-assembly method. Carbohydr. Polym. 2011, 84, 765-769.
20. Butun S, Ince FG, Erdugan H, Sahiner N. One-step fabrication of biocompatible carboxymethyl cellulose polymeric particles for drug delivery systems. Carbohydr. Polym. 2011, 86, 636-643.
21. Uekama K. Recent aspects of pharmaceutical application of cyclodextrins. J. Incl. Phenom. Macro. 2002, 44, 3-7.
22. Tassa C, Shaw SY, Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc. Chem. Res. 2011, 44, 842-852.
23. Alvarez-Lorenzo C, Blanco-Fernandez B, Puga AM, Concheiro A. Crosslinked ionic polysaccharides for stimuli-sensitive drug delivery. Adv. Drug Delivery Rev. 2013, 65, 1148-1171.
24. Daoud-Mahammed S, Couvreur P, Bouchemal K, Chéron M, Lebas G, Amiel C, Gref R. Cyclodextrin and polysaccharidebased nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen. Biomacromolecules 2009, 10, 547-554.
25. Liu Y, Zhao YL, Zhang HY. Recognition-induced supramolecular porous nanosphere formation from cyclodextrin conjugated by cholic acid. Langmuir 2006, 22, 3434-3438.
26. Auzély-Velty R. Self-assembling polysaccharide systems based on cyclodextrin complexation: synthesis, properties and potential applications in the biomaterials field. Comptes. Rendus. Chimie. 2011, 14, 167-177.
27. Harada A, Kamachi M. Complex formation between poly(ethylene glycol) and α-cyclodextrin. Macromolecules 1990, 23, 2821-2823.
28. Davis ME. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm. 2009, 6, 659-668.
29. Nanotechnology in Clinical Trials. http://nano.cancer.gov/learn/now/clinical-trials.asp (accessed January 1, 2014).
30. Choisnard L, Geze A, Putaux J, Wong Y, Wouessidjewe D. Nanoparticles of b-cyclodextrin esters obtained by self-assembling of biotransesterified b-cyclodextrins. Biomacromolecules 2006, 7, 515-520.
31. Yaméogo JBG, Gèze A, Choisnard L, Putaux J, Gansané A, Sirima SB, Semdé R, Wouessidjewe D. Self-assembled biotransesterified cyclodextrins as artemisinin nanocarriers - I: Formulation, lyoavailability and in vitro antimalarial activity assessment. Eur. J. Pharm. Biopharm. 2012, 80, 508-517.
32. van Agtmael MA, Eggelte TA, van Boxtel CJ. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol. Sci. 1999, 20, 199-205.
33. Wong JW, Yuen KH. Inclusion complexation of artemisinin with α-, β-, and γ-cyclodextrins. Drug Dev. Ind. Pharm. 2003, 29, 1035-1044.
34. Qin J, Meng X, Li B, Ha W, Yu X, Zhang S. Self-assembly of β-cyclodextrin and pluronic into hollow nanospheres in aqueous solution. J. Colloid Interface Sci. 2010, 350, 447-452.
35. Lasic, DD, Papahadjopoulos, D. Liposomes in medicine. In Medical Applications of Liposomes, Lasic, DD, Papahadjopoulos, D, Eds., Elsevier Science B.V.: Amsterdam, 1998, pp. 1-7.
36. Saltzman, WM. Drug Delivery: Engineering Principles for Drug Therapy, Oxford University Press: Oxford England, 2001.
37. Letchford K, Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur. J. Pharm. Biopharm. 2007, 65, 259-269.
38. Liu KH, Chen BR, Chen SY, Liu DM. Self-assembly behavior and doxorubicin-loading capacity of acylated carboxymethyl chitosans. J. Phys. Chem. B 2009, 113, 11800-11807.
39. Liu KH, Chen SY, Liu DM, Liu TY. Self-assembled hollow nanocapsule from amphiphatic carboxymethyl-hexanoyl chitosan as drug carrier. Macromolecules 2008, 41, 6511-6516.
40. Wang Y, Chien Y, Wu C, Liu D. Magnolol-loaded core-shell hydrogel nanoparticles: drug release, intracellular uptake, and controlled cytotoxicity for the inhibition of migration of vascular smooth muscle cells. Mol. Pharm. 2011, 8, 2339-2349.
41. Lee SJ, Hong G, Jeong Y, Kang M, Oh J, Song C, Lee HC. Paclitaxelincorporated nanoparticles of hydrophobized polysaccharide and their antitumor activity. Int. J. Pharm. 2012, 433, 121-128.
42. Zhang N, Wardwell PR, Bader RA. Polysaccharide-based micelles for drug delivery. Pharmaceutics 2013, 5, 329-352.
43. World Health Organization. Visual impairment and blindness. http://www.who.int/mediacentre/factsheets/fs282/en/(accessed October 28, 2013).
44. Koo H, Moon H, Han H, Na JH, Huh MS, Park JH, Woo SJ, Park KH, Chan Kwon I, Kim K, Kim H. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Biomaterials 2012, 33, 3485-3493.
45. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang Y, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980. Lancet 2011, 378, 31-40.
46. Akiyoshi K, Kobayashi S, Shichibe S, Mix D, Baudys M, Wan Kim S, Sunamoto J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Controlled Release 1998, 54, 313-320.
47. Rodrigues S, Dionísio M, López CR, Grenha A. Biocompatability of chitosan carriers with application in drug delivery. J. Funct. Biomater. 2012, 3, 615-641.
48. Raafat D, von Bargen K, Haas A, Sahl H. Insights into the mode of action of chitosan as an antibacterial compound. Appl. Environ. Microbiol. 2008, 74, 3764-3773.
49. Ma PL, Lavertu M, Winnik FM, Buschmann MD. New insights into chitosan-DNA interactions using isothermal titration microcalorimetry. Biomacromolecules 2009, 10, 1490-1499.
50. Fallingborg J. Intraluminal pH of the human gastrointestinal tract. Dan. Med. Bull. 1999, 46, 183-196.
51. Oishi M, Hayashi H, Iijima M, Nagasaki Y. Endosomal release and intracellular delivery of anticancer drugs using pH-sensitive PEGylated nanogels. J. Mater. Chem. 2007, 17, 3720-3725.
52. Gao W, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Mol. Pharmaceutics 2010, 7, 1913-1920.
53. Chen J, Huang L, Lai H, Lu C, Fang M, Zhang Q, Luo X. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity. Mol. Pharm. doi: 10.1021/mp400269z.
54. Lian H, Zhang T, Sun J, Liu X, Ren G, Kou L, Zhang Y, Han X, Ding W, Ai X, Wu C, Li L, Wang Y, Sun Y, Wang S, He Z. Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism. Mol. Pharm. 2013, 10, 3447-3458.
55. Rabenstein DL. Heparin and heparan sulfate: structure and function. Nat. Prod. Rep. 2002, 19, 312-331.
56. Sharath MD, Merchant ZM, Kim YS, Rice KG, Linhardt RJ, Weiler JM. Small heparin fragments regulate the amplification pathway of complement. Immunopharmacology 1985, 9, 73-80.
57. Folkman J, Shing Y. Control of angiogenesis by heparin and other sulfated polysaccharides. Adv. Exp. Med. Bio. 1992, 313, 355.
58. Tang D, Yu S, Ho Y, Mi F, Kuo P, Sung H. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin. Biomaterials 2010, 31, 9320-9332.
59. Dowling MB, Kumar R, Keibler MA, Hess JR, Bochicchio GV, Raghavan SR. A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action. Biomaterials 2011, 32, 3351-3357.
60. Dai T, Tanaka M, Huang YY, Hamblin MR. Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev. Anti Infect. Ther. 2011, 9, 857-879.
61. Hu L, Sun Y, Wu Y. Advances in chitosan-based drug delivery vehicles. Nanoscale 2013, 5, 3103-3111.
62. Ravi Kumar MNV. A review of chitin and chitosan applications. React. Funct. Polym. 2000, 46, 1-27.
63. Nadesh R, Narayanan DPRS, Vadakumpully S, Mony U, Koyakkutty M, Nair SV, Menon D. Hematotoxicological analysis of surface-modified and -unmodified chitosan nanoparticles. J. Biomed. Mater. Res., Part A 2013, 101, 2957-2966.
64. De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm. Res. 2000, 17, 113-126.
65. Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Controlled Release 2006, 114, 100-109.
66. Wen Y, Pan S, Luo X, Zhang X, Zhang W, Feng M. A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector. Bioconjugate Chem. 2009, 20, 322-332.
67. Liu WG, Yao KD. Chitosan and its derivatives - a promising non-viral vector for gene transfection. J. Controlled Release 2002, 83, 1-11.
68. Loretz B, Bernkop-Schnürch A. In vitro cytotoxicity testing of non-thiolated and thiolated chitosan nanoparticles for oral gene delivery. Nanotoxicology 2007, 1, 139-148.
69. Loh JW, Saunders M, Lim L. Cytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells. Toxicol. Appl. Pharmacol. 2012, 262, 273-282.
70. Morimoto N, Hirano S, Takahashi H, Loethen S, Thompson DH, Akiyoshi K. Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle. Biomacromolecules 2013, 14, 56-63.
71. Park JS, Han TH, Lee KY, Han SS, Hwang JJ, Moon DH, Kim SY, Cho YW. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J. Controlled Release 2006, 115, 37-45.
72. Schild H. Poly(N-isopropylacrylamide): experiment, theory and application. Prog. Polym. Sci. 1992, 17, 163-249.
73. Pelton R. Temperature-sensitive aqueous microgels. Adv. Colloid Interface Sci. 2000, 85, 1-33.
74. Hoffman AS. Applications of thermally reversible polymers and hydrogels in therapeutics and diagnostics. J. Controlled Release 1987, 6, 297-305.
75. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Delivery Rev. 2001, 53, 321-339.
76. Bromberg LE, Ron ES. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv. Drug Delivery Rev. 1998, 31, 197-221.
77. Fan L, Wu H, Zhang H, Li F, Yang T. pH-sensitive podophyllotoxin carrier for cancer cells specific delivery. Polym. Compos. 2009, 31, 51-59.
78. Dolmans DEJGJ, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380.
79. Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV. Nanodrug applications in photodynamic therapy. Photodiagnosis Photodyn. Ther. 2011, 8, 14-29.
80. Lee SJ, Koo H, Lee D, Min S, Lee S, Chen X, Choi Y, Leary JF, Park K, Jeong SY, Kwon IC, Kim K, Choi K. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. Biomaterials 2011, 32, 4021-4029.
81. Lee SJ, Koo H, Jeong H, Huh MS, Choi Y, Jeong SY, Byun Y, Choi K, Kim K, Kwon IC. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J. Controlled Release 2011, 152, 21-29.
82. Li L, Bae B, Tran TH, Yoon KH, Na K, Huh KM. Self-quenchable biofunctional nanoparticles of heparin-folate-photosensitizer conjugates for photodynamic therapy. Carbohydr. Polym. 2011, 86, 708-715.
83. Oh I, Min HS, Li L, Tran TH, Lee Y, Kwon IC, Choi K, Kim K, Huh KM. Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. Biomaterials 2013, 34, 6454-6463.
84. Larson N, Ghandehari H. Polymeric conjugates for drug delivery. Chem. Mater. 2012, 24, 840-853.
85. Vemula PK, Wiradharma N, Ankrum JA, Miranda OR, John G, Karp JM. Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials. Curr. Opin. Biotechnol. 2013, 24, 1174-1182.
86. Pang X, Du H, Zhang H, Zhai Y, Zhai G. Polymer-drug conjugates: present state of play and future perspectives. Drug Discov. Today 2013, 18, 1316-1322.
87. Patil R, Portilla-Arias J, Ding H, Konda B, Rekechenetskiy A, Inoue S, Black, KL, Holler E, Ljubimova JY. Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(b-L-malic acid). Int. J. Mol. Sci. 2012, 13, 11681-11693.
88. Wang Y, Xin D, Liu K, Zhu M, Xiang J. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity. Bioconjugate Chem. 2009, 20, 2214-2221.
89. Chu H, Johnson NR, Mason NS, Wang Y. A polycation:heparin complex releases growth factors with enhanced bioactivity. J. Controlled Release 2011, 150, 157-163.
90. Sonvico F, Cagnani A, Rossi A, Motta S, Di Bari MT, Cavatorta F, Alonso MJ, Deriu A, Colombo P. Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int. J. Pharm. 2006, 324, 67-73.
91. Chen L, Remondetto GE, Subirade M. Food protein-based materials as nutraceutical delivery systems. Trends Food Sci. Technol. 2006, 17, 272-283.
92. Huang Q, Yu H, Ru Q. Bioavailability and delivery of nutraceuticals using nanotechnology. J. Food Sci. 2010, 75, 50-57.
93. Clarke R, Smith A, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed alzheimer disease. Arch. Neurol. 1998, 55, 1449-1455.
94. Off MK, Steindal AE, Porojnicu AC, Juzeniene A, Vorobey A, Johnsson A, Moan J. Ultraviolet photodegradation of folic acid. J. Photochem. Photobiol. B 2005, 80, 47-55.
95. Yang S, Lin F, Tsai K, Wei M, Tsai H, Wong J, Shieh M. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjugate Chem. 2010, 21, 679-689.
96. Sun G, Chu C. Self-assembly of chemically engineered hydrophilic dextran into microscopic tubules. ACS Nano 2009, 3, 1176-1182.
97. Huang X, Teng X, Chen D, Tang F, He J. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 2010, 31, 438-448.
98. Decher G, Hong J. Buildup of ultrathin multilayer films by a self-assembly process: I. Consecutive adsorption of anionic and cationic bipolar amphiphiles on charged surfaces. Makro. Chem. Macro. Sym. 1991, 46, 321-327.
99. Decher G, Hong JD. Buildup of ultrathin multilayer films by a self-assembly process: II. Consecutive adsorption of anionic and cationic bipolar amphiphiles and polyelectrolytes on charged surfaces. Berichte der Bunsengesellschaft für physikalische Chemie 1991, 95, 1430-1434.
100. de Villiers MM, Otto DP, Strydom SJ, Lvov YM. Introduction to nanocoatings produced by layer-by-layer (LbL) self-assembly. Adv. Drug Delivery Rev. 2011, 63, 701-715.
101. Kikuchi A, Okano T. Pulsatile drug release control using hydrogels. Adv. Drug Delivery Rev. 2002, 54, 53-77.
102. De Luca F, Baron J. Control of bone growth by fibroblast growth factors. Trends Endocrinol. Metab. 1999, 10, 61-65.
103. AlmodÓvar J, Bacon S, Gogolski J, Kisiday JD, Kipper MJ.Polysaccharide-based polyelectrolyte multilayer surface coatings can enhance mesenchymal stem cell response to adsorbed growth factors. Biomacromolecules 2010, 11, 2629-2639.
104. de Fougerolles A, Lieberman J, Maraganore J, Vornlocher H. Interfering with disease: a progress report on siRNA-based therapeutics. Nat. Rev. Drug Disc. 2007, 6, 443.
105. Han L, Zhao J, Zhang X, Cao W, Hu X, Zou G, Duan X, Liang X. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assemblyand good biocompatibility. ACS Nano 2012, 6, 7340-7351.
106. Cao Y, Shen X, Chen Y, Guo J, Chen Q, Jiang X. pH-induced self-assembly and capsules of sodium alginate. Biomacromolecules 2005, 6, 2189-2196.
107. Shutava TG, Balkundi SS, Vangala P, Steffan JJ, Bigelow RL, Cardelli JA, O'Neal DP, Lvov YM. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano 2009, 3, 1877-1885.
108. Amiji M, Kommareddy S. Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors. Cancer Gene Ther. 2007, 14, 488.
109. Kommareddy S, Amiji M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J. Pharm. Sci. 2007, 96, 397-407.
110. Zhu H, Liu F, Guo J, Xue J, Qian Z, Gu Y. Folate-modified chitosan micelles with enhanced tumor targeting evaluated by near infrared imaging system. Carbohydr. Polym. 2011, 86, 1118-1129.
111. Lee C, Jang D, Kim J, Cheong S, Kim E, Jeong M, Kim S, Kim DW, Lim ST, Sohn M, Jeong YY, Jeong H. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo. Bioconjugate Chem. 2011, 22, 186-192.
112. Rai P, Mallidi S, Zheng X, Rahmanzadeh R, Mir Y, Elrington S, Khurshid A, Hasan T. Development and applications of photo-triggered theranostic agents. Adv. Drug Delivery Rev. 2010, 62, 1094-1124.
113. Lammers T, Kiessling F, Hennink WE, Storm G. Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol. Pharm. 2010, 7, 1899-1912.
114. Kim S-H, Nguyen TH, Maynard HD. Polymeric drug conjugates by controlled radical polymerization. In Comprehensive Biomaterials, Volume 4: Biocompatibility, Surface Engineering, and Delivery of Drugs, Genes and Other Molecules, Ducheyne, P, Ed., Elsevier: Oxford, 2011, pp. 377-388.
115. Rocha N, Mendonça P, Góis JR, Cordeiro R, Fonesca A, Ferreira P, Guliashvili T, Matyjaszewski K, Serra A, Coehlo J. The importance of controlled/living radical polymerization in the design of tailor made nanoparticles for drug delivery systems. In Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment, Coelho, J, Ed., Springer: Netherlands, 2013, pp. 315-357.
116. Neuse EW. Synthetic polymers as drug-delivery vehicles in medicine. Met. Based Drugs 2008, 2008.
117. Zhu J, Shi X. Dendrimer-based nanodevices for targeted drug delivery applications. J. Mater. Chem. B 2013, 1, 4199-4211.
118. Jonker AM, Löwik DWPM, van Hest JCM. Peptide- and proteinbased hydrogels. Chem. Mater. 2012, 24, 759-773.
119. Ischakov R, Adler-Abramovich L, Buzhansky L, Shekhter T, Gazit E. Peptide-based hydrogel nanoparticles as effective drug delivery agents. Bioorg. Med. Chem. 2013, 21,3517-3522.
120. Wagh A, Singh J, Qian S, Law B. A short circulating peptide nanofiber as a carrier for tumoral delivery. Nanomed.Nanotech. Biol. Med. 2013, 9, 449-457.
121. Deshayes S, Morris M, Heitz F, Divita G. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv. Drug Delivery Rev. 2008, 60, 537-547.
122. Jiang H, Sun P, He J, Shao P. Rapid purification of polysaccharides using novel radial flow ion-exchange by response surface methodology from Ganoderma lucidum. Food Bioprod. Process. 2012, 90, 1-8.
123. Takahashi H, Sawada S, Akiyoshi K. Amphiphilic polysaccharidenanoballs: a new building block for nanogel biomedical engineering and artificial chaperones. ACS Nano 2011, 5, 337-345.
124. Ruffing A, Chen RR. Metabolic engineering of microbes for oligosaccharide and polysaccharide synthesis. Microb. Cell Fact. 2006, 5, 25.
125. Teeri TT. Carbohydrate Bioengineering: Interdisciplinary Approaches, Royal Society of Chemistry: Cambridge, UK, 2002.
126. Joshi VS, Bajaj IB, Survase SA, Singhal RS, Kennedy JF. Meningococcal polysaccharide vaccines: a review. Carbohydr. Polym. 2009, 75, 553-565.
127. Wardrop D, Keeling D. The story of the discovery of heparin and warfarin. Br. J. Haematol. 2008, 141, 757-763.
128. Kamel S, Ali N, Jahangir K, Shah SM, El-Gendy AA. Pharmaceutical significance of cellulose: a review. Express Polym. Lett. 2008, 2, 758-778.
129. Rodrigues A, Emeje M. Recent applications of starch derivatives in nanodrug delivery. Carbohydr. Polym. 2012, 87, 987-994.
130. Pawar SN, Edgar KJ. Alginate derivatization: a review of chemistry, properties and applications. Biomaterials 2012, 33, 3279-3305.
131. Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog. Polym. Sci. 2012, 37, 106-126.
132. Prajapati VD, Maheriya PM, Jani GK, Solanki HK. Carrageenan: a natural seaweed polysaccharide and its applications. Carbohydr. Polym. 2014, 105, 97-112.